Pyxis Oncology (PYXS) Common Equity (2020 - 2026)
Pyxis Oncology's Common Equity came in at $11.44 million for Q2 2026, down 86.9% from $87.64 million a year earlier.
Powered by 
Analysis
Pyxis Oncology (PYXS) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Pyxis Oncology's Common Equity was $53.41 million, down 55.8% from FY2024.
- Common Equity has declined in each of the last four years.
- Going back by year, Common Equity was $120.75 million in FY2024 (-3.9%), $125.7 million in FY2023 (-21.8%), $160.82 million in FY2022 (-38.5%) and $261.31 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q3 2021.
- Year-over-year, Common Equity increased in 1 of the last seven quarters, with an average decline of 40.4%.
- The fastest year-over-year change in Common Equity over five years came in Q1 2024 (growth of 21.0%), and the weakest in Q2 2026 (a decline of 86.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Pyxis Oncology | 112.79 Mn | -152.27 Mn | - | 11.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.44 Mn |
| Dec 31, 2025 | 53.41 Mn |
| Sep 30, 2025 | 68.78 Mn |
| Jun 30, 2025 | 87.64 Mn |
| Mar 31, 2025 | 103.10 Mn |
| Dec 31, 2024 | 120.75 Mn |
| Sep 30, 2024 | 153.68 Mn |
| Jun 30, 2024 | 169.79 Mn |
| Mar 31, 2024 | 184.16 Mn |
| Dec 31, 2023 | 125.70 Mn |
| Sep 30, 2023 | 137.95 Mn |
| Jun 30, 2023 | 145.28 Mn |
| Mar 31, 2023 | 152.16 Mn |
| Dec 31, 2022 | 160.82 Mn |
| Sep 30, 2022 | 188.75 Mn |
| Jun 30, 2022 | 211.97 Mn |
| Mar 31, 2022 | 233.51 Mn |
| Dec 31, 2021 | 261.31 Mn |
| Sep 30, 2021 | -71.44 Mn |
| Jun 30, 2021 | -57.59 Mn |
API Access
Pyxis Oncology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PYXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PYXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PYXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();